These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 28630896)
1. The GH receptor exon 3 deletion is a marker of male-specific exceptional longevity associated with increased GH sensitivity and taller stature. Ben-Avraham D; Govindaraju DR; Budagov T; Fradin D; Durda P; Liu B; Ott S; Gutman D; Sharvit L; Kaplan R; Bougnères P; Reiner A; Shuldiner AR; Cohen P; Barzilai N; Atzmon G Sci Adv; 2017 Jun; 3(6):e1602025. PubMed ID: 28630896 [TBL] [Abstract][Full Text] [Related]
2. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. Binder G; Baur F; Schweizer R; Ranke MB J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706 [TBL] [Abstract][Full Text] [Related]
3. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study. Baş F; Darendeliler F; Aycan Z; Çetinkaya E; Berberoğlu M; Sıklar Z; Öcal G; Timirci Ö; Çetinkaya S; Darcan Ş; Gökşen Şimşek D; Bideci A; Cinaz P; Böber E; Demir K; Bereket A; Turan S; Atabek ME; Tütüncüler F; Isbir T; Bozkurt N; Kabataş Eryılmaz S; Uzunhan O; Küçükemre Aydın B; Bundak R Horm Res Paediatr; 2012; 77(2):85-93. PubMed ID: 22456308 [TBL] [Abstract][Full Text] [Related]
4. Association of the exon 3 deleted/full-length GHR polymorphism with recombinant growth hormone dose in growth hormone-deficient adults. Meyer S; Schaefer S; Stolk L; Arp P; Uitterlinden AG; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Weise A; Pfützner A; Kann PH Pharmacogenomics; 2009 Oct; 10(10):1599-608. PubMed ID: 19842933 [TBL] [Abstract][Full Text] [Related]
5. Influence of the exon 3 deletion of GH receptor and IGF-I level at diagnosis on the efficacy and safety of treatment with somatotropin in adults with GH deficiency. Andujar-Plata P; Fernandez-Rodriguez E; Quinteiro C; Casanueva FF; Bernabeu I Pituitary; 2015 Feb; 18(1):101-7. PubMed ID: 24710993 [TBL] [Abstract][Full Text] [Related]
6. The exon3-deleted growth hormone receptor gene polymorphism (d3-GHR) is associated with insulin and spontaneous growth in short SGA children (NESGAS). Wegmann MG; Thankamony A; Roche E; Hoey H; Kirk J; Shaikh G; Ivarsson SA; Söder O; Dunger DB; Juul A; Jensen RB Growth Horm IGF Res; 2017 Aug; 35():45-51. PubMed ID: 28719834 [TBL] [Abstract][Full Text] [Related]
7. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis. Wassenaar MJ; Dekkers OM; Pereira AM; Wit JM; Smit JW; Biermasz NR; Romijn JA J Clin Endocrinol Metab; 2009 Oct; 94(10):3721-30. PubMed ID: 19584188 [TBL] [Abstract][Full Text] [Related]
8. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency. Jorge AA; Marchisotti FG; Montenegro LR; Carvalho LR; Mendonca BB; Arnhold IJ J Clin Endocrinol Metab; 2006 Mar; 91(3):1076-80. PubMed ID: 16291702 [TBL] [Abstract][Full Text] [Related]
9. Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature. Toyoshima MT; Castroneves LA; Costalonga EF; Mendonca BB; Arnhold IJ; Jorge AA Clin Endocrinol (Oxf); 2007 Oct; 67(4):500-4. PubMed ID: 17555512 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH) receptor isoform in acromegaly: lower concentrations of GH but not insulin-like growth factor-1 in patients with a genomic deletion of exon 3 in the GH receptor gene. Schmid C; Krayenbuehl PA; Bernays RL; Zwimpfer C; Maly FE; Wiesli P Clin Chem; 2007 Aug; 53(8):1484-8. PubMed ID: 17573420 [TBL] [Abstract][Full Text] [Related]
11. The distribution of exon 3-deleted/full-length growth hormone receptor polymorphism in the Turkish population. Baş F; Keleşoğlu F; Timirci Ö; Kabataş Eryılmaz S; Bozkurt N; Küçükemre Aydın B; Bundak R; Isbir T; Darendeliler F J Clin Res Pediatr Endocrinol; 2011; 3(3):126-31. PubMed ID: 21911325 [TBL] [Abstract][Full Text] [Related]
12. The common exon 3 polymorphism of the growth hormone receptor gene and the effect of growth hormone therapy on growth in Korean patients with Turner syndrome. Ko JM; Kim JM; Cheon CK; Kim DH; Lee DY; Cheong WY; Kim EY; Park MJ; Yoo HW Clin Endocrinol (Oxf); 2010 Feb; 72(2):196-202. PubMed ID: 19681916 [TBL] [Abstract][Full Text] [Related]
13. A polymorphism in the growth hormone receptor is associated with height in children with Prader-Willi syndrome. Park SW; Lee ST; Sohn YB; Kim SH; Cho SY; Ko AR; Ji ST; Kwon JY; Yeau S; Paik KH; Kim JW; Jin DK Am J Med Genet A; 2011 Dec; 155A(12):2970-3. PubMed ID: 22052808 [TBL] [Abstract][Full Text] [Related]
14. d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype. Montefusco L; Filopanti M; Ronchi CL; Olgiati L; La-Porta C; Losa M; Epaminonda P; Coletti F; Beck-Peccoz P; Spada A; Lania AG; Arosio M Clin Endocrinol (Oxf); 2010 May; 72(5):661-7. PubMed ID: 20447065 [TBL] [Abstract][Full Text] [Related]
15. Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. Bianchi A; Giustina A; Cimino V; Pola R; Angelini F; Pontecorvi A; De Marinis L J Clin Endocrinol Metab; 2009 Jun; 94(6):2015-22. PubMed ID: 19336510 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) dose, but not exon 3-deleted/full-length GH receptor polymorphism genotypes, influences growth response to two-year GH Therapy in Short Small-for-Gestational-Age Children. Carrascosa A; Audí L; Esteban C; Fernández-Cancio M; Andaluz P; Gussinyé M; Clemente M; Yeste D; Albisu MA J Clin Endocrinol Metab; 2008 Jan; 93(1):147-53. PubMed ID: 17925340 [TBL] [Abstract][Full Text] [Related]
17. Influence of growth hormone (GH) receptor deletion of exon 3 and full-length isoforms on GH response and final height in patients with severe GH deficiency. Räz B; Janner M; Petkovic V; Lochmatter D; Eblé A; Dattani MT; Hindmarsh PC; Flück CE; Mullis PE J Clin Endocrinol Metab; 2008 Mar; 93(3):974-80. PubMed ID: 18029459 [TBL] [Abstract][Full Text] [Related]
18. The growth response to growth hormone (GH) treatment in children with isolated GH deficiency is independent of the presence of the exon 3-minus isoform of the GH receptor. Blum WF; Machinis K; Shavrikova EP; Keller A; Stobbe H; Pfaeffle RW; Amselem S J Clin Endocrinol Metab; 2006 Oct; 91(10):4171-4. PubMed ID: 16868057 [TBL] [Abstract][Full Text] [Related]
19. d3-GHR genotype does not explain heterogeneity in GH responsiveness in hypopituitary adults. Moyes VJ; Walker DM; Owusu-Antwi S; Maher KT; Metherell L; Akker SA; Monson JP; Clark AJ; Drake WM Clin Endocrinol (Oxf); 2010 Jun; 72(6):807-13. PubMed ID: 20039885 [TBL] [Abstract][Full Text] [Related]
20. Growth hormone receptor exon 3 isoforms may have no importance in the clinical setting of multiethnic Brazilian acromegaly patients. de Oliveira Machado E; Lima CH; Ogino LL; Kasuki L; Gadelha MR Pituitary; 2016 Aug; 19(4):375-80. PubMed ID: 27001494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]